Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-028049
Filing Date
2023-06-02
Accepted
2023-06-02 16:15:43
Documents
5
Period of Report
2023-07-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20009103x2_def14a.htm DEF 14A 804649
2 ny20009103x2_barchart01.jpg GRAPHIC 77966
3 ny20009103x2_barchart02.jpg GRAPHIC 79106
4 ny20009103x2_pc1.jpg GRAPHIC 615611
5 ny20009103x2_pc2.jpg GRAPHIC 390019
  Complete submission text file 0001140361-23-028049.txt   2406050
Mailing Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

EIN.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37568 | Film No.: 23988926
SIC: 2834 Pharmaceutical Preparations